Novel Anticancer Triple Formula Based on Aptamer-Conjugated PEGylated Nanoliposomes
Background Cancer remains a leading cause of death worldwide, necessitating the development of affordable and innovative therapies to reduce its human and economic burden. Objectives In this study, we aimed to develop a synergistic anticancer formula encapsulated in nanoliposomes to enhance efficacy...
Saved in:
Main Authors: | Ali Al-Samydai PhD, Hamdi Nsairat PhD, Moath Alqaraleh PhD, Maha N. Abu Hajleh PhD, Areej Jaber PhD, Lidia Al-Halaseh PhD, Hanan Azzam MS, Qasim Khalid Alazzawi PhD, Israa Al-Ani PhD, Simone Carradori PhD, Walhan Alshaer PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-07-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338251356548 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Balancing religious obligations and cultural integration—female foreign Muslims’ healthcare experiences in Japan: a qualitative study
by: Ayako Kohno, PhD, et al.
Published: (2025-05-01) -
Patient Perceptions on the Role of Informal Caregiver Support in Managing Advanced COPD
by: Barbara Gonçalves PhD, et al.
Published: (2025-07-01) -
Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa
by: Thomas Leeuw, PhD, et al.
Published: (2025-08-01) -
Histological evaluation of osteogenesis using stem cells from human exfoliated deciduous teeth seeded in polymethylmethacrylate-hydroxyapatite scaffold
by: Tania Saskianti, PhD, et al.
Published: (2025-08-01) -
Beyond the expected: MRI features of a primary retro-uterine neuroendocrine tumor: A case report
by: Zineb Ezzoulali, MD, et al.
Published: (2025-10-01)